Craig Hunsaker Sells 32,584 Shares of Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Craig Hunsaker sold 32,584 shares of the stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $20.84, for a total transaction of $679,050.56. Following the completion of the sale, the executive vice president directly owned 1,256,558 shares in the company, valued at $26,186,668.72. This trade represents a 2.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Alphatec Stock Performance

Shares of Alphatec stock opened at $19.96 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.99 and a debt-to-equity ratio of 43.02. The stock’s fifty day moving average is $18.42 and its two-hundred day moving average is $15.10. Alphatec Holdings, Inc. has a 52 week low of $8.69 and a 52 week high of $22.66. The company has a market capitalization of $2.97 billion, a PE ratio of -19.19 and a beta of 1.08.

Alphatec (NASDAQ:ATEC) last posted its quarterly earnings results on Thursday, October 30th. The medical technology company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. The company had revenue of $196.50 million for the quarter, compared to the consensus estimate of $182.78 million. During the same period in the prior year, the firm posted ($0.28) EPS. The business’s revenue was up 30.4% on a year-over-year basis. As a group, analysts expect that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ATEC. Aster Capital Management DIFC Ltd acquired a new position in Alphatec during the third quarter worth about $34,000. Osterweis Capital Management Inc. purchased a new stake in Alphatec in the 2nd quarter valued at $37,000. Nisa Investment Advisors LLC increased its stake in shares of Alphatec by 22.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 5,714 shares of the medical technology company’s stock worth $63,000 after acquiring an additional 1,045 shares during the last quarter. China Universal Asset Management Co. Ltd. purchased a new position in shares of Alphatec during the 3rd quarter worth $73,000. Finally, FORA Capital LLC acquired a new position in shares of Alphatec during the 1st quarter valued at about $102,000. 66.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on ATEC. Morgan Stanley set a $23.00 price target on shares of Alphatec in a report on Tuesday, December 2nd. Loop Capital set a $25.00 target price on Alphatec in a research note on Wednesday. HC Wainwright upped their target price on Alphatec from $20.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Stifel Nicolaus assumed coverage on Alphatec in a research note on Tuesday, October 28th. They issued a “buy” rating and a $20.00 price target for the company. Finally, Wells Fargo & Company boosted their price target on Alphatec from $14.00 to $16.00 and gave the stock an “overweight” rating in a research note on Thursday, October 16th. Nine equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.45.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.